Cancer Prognosis and Survival Rates Explained

By the Oncol.net editorial team · Last updated November 1, 2026

A prognosis is your doctor's best estimate of how a cancer is likely to go. It is an educated guess, not a prediction. Survival rates show what happened to large groups of people. In the US, 70% of people diagnosed with cancer in 2015 to 2021 were alive 5 years later, relative to the general population. Rates range widely by cancer type and stage.

Whether to look at these numbers is your choice. Some people find them useful, and others would rather not know. Both are reasonable. If you read on, keep in mind that your own doctor can say far more about you than any table can.

What affects prognosis

The National Cancer Institute lists these main factors:

The type of cancer and where it is in the body
The stage, meaning how far it has spread
The grade, meaning how abnormal the cells look
Traits of the cancer cells, such as gene changes
Your age and overall health
How well the cancer responds to treatment

Relative survival, overall survival and other terms

Term	What it means
5-year relative survival	Compares people with a cancer to similar people in the general population. A rate of 80% means people with that cancer were about 80% as likely to be alive 5 years later as similar people without it.
Overall survival	The percentage of people who have not died from any cause over a set time. It counts heart disease, accidents and everything else.
Cancer-specific survival	The percentage who have not died from their cancer over a set time. It relies on recorded causes of death.
Disease-free survival	The percentage with no sign of cancer for a set time after treatment. Also called recurrence-free or progression-free survival.

Relative survival is the figure most often quoted because it removes other causes of death. This matters for cancers of older adults. Older people die of other causes, so overall survival can look worse than the cancer alone would explain. It is also why you can see 100% for some early cancers. That means people lived about as long as similar people without the cancer, not that nobody died.

Five years is only a convention. It is not a cure line and it is not a limit. Many people live far past 5 years.

Localized, regional and distant

US survival data come from the National Cancer Institute's SEER cancer registries. SEER uses three main stages rather than stages I to IV:

Localized: the cancer has stayed where it started.
Regional: it has reached nearby lymph nodes, tissues or organs.
Distant: it has spread to distant parts of the body. This is close to stage 4, but not identical.

The match to TNM stages is rough. For instance, nearby lymph nodes make a prostate cancer stage IVA but SEER regional. Also, SEER figures apply to stage at first diagnosis.

5-year relative survival by cancer and SEER stage

Data: people diagnosed 2016 to 2022 (SEER 21, excluding Illinois). The breast row is female breast cancer.

Cancer	Localized	Regional	Distant	All stages
Breast	100.0%	87.5%	33.8%	91.9%
Prostate	100.0%	100.0%	40.1%	98.2%
Lung	65.5%	38.2%	10.5%	29.5%
Colorectal	91.3%	75.2%	16.9%	65.4%
Melanoma	100.0%	76.0%	34.0%	94.7%
Bladder	73.0%	41.8%	9.6%	79.1%
Kidney	93.6%	77.6%	20.3%	79.2%
Uterine	94.9%	70.1%	19.9%	80.9%
Cervical	91.8%	64.0%	20.5%	68.8%
Ovarian	91.9%	70.1%	31.5%	52.0%
Pancreatic	43.6%	17.0%	3.4%	13.7%
Liver	37.4%	13.4%	3.6%	21.9%
Stomach	78.1%	39.0%	8.1%	39.8%
Esophageal	48.6%	29.1%	5.3%	22.2%
Thyroid	99.9%	98.1%	48.3%	98.3%

Why can "all stages" be higher than the localized figure, as for bladder cancer? Half of bladder cancers are found in situ, the earliest stage, with 98.0% survival, and that group is not shown here. The all-stages figure also depends on how many people are found at each stage. Ovarian cancer's 52.0% is low mostly because 54% of cases are found at the distant stage.

Testicular cancer is shown differently, because SEER's summary page has no stage table. The American Cancer Society reports 99% localized, 96% regional and 72% distant, for people diagnosed 2015 to 2021.

Why statistics do not predict one person's future

They come from groups. A 30% rate describes a large group. It cannot say which people in that group will live past 5 years.
They are out of date by design. Five-year figures need 5 years of follow-up. All-cancer distant-stage survival rose from 17% in the mid-1990s to 35% for people diagnosed in 2015 to 2021. Over the same period, myeloma rose from 32% to 62%, and liver cancer from 7% to 22%. Newer treatments may not yet be counted.
They blend different people. They mix ages, health and tumor types. Two people with the same stage can have very different biomarkers.
They stop at diagnosis. They do not change with how your cancer responds.

Ovarian cancer survival by stage and early signs

People often look up the signs of ovarian cancer and survival rates together, because stage at diagnosis matters so much. Overall 5-year relative survival is 52.0%. It is 91.9% when the cancer is found while localized, but only 22% of cases are found then.

SEER stage	Share of cases	5-year relative survival (2016 to 2022)
Localized (roughly stage I)	22%	91.9%
Regional	18%	70.1%
Distant	54%	31.5%
All stages	100%	52.0%

Shares do not add to 100% because 6% of cases are unstaged and not shown. Survival also depends on tumor type. For people diagnosed 2015 to 2021, the American Cancer Society reports:

Tumor type	Localized	Regional	Distant	All stages
Invasive epithelial (the most common type)	92%	71%	32%	51%
Stromal	96%	88%	75%	91%
Germ cell	98%	94%	76%	93%

Early signs of ovarian cancer

Ovarian cancer is often called silent, but it does cause symptoms. They are easy to dismiss. The most common are:

Bloating
Pelvic or belly pain
Trouble eating, or feeling full quickly
Needing to urinate urgently or often

Other possible symptoms are fatigue, upset stomach, back pain, pain during sex, constipation, changes in periods, and belly swelling with weight loss.

These symptoms usually have other causes. They matter more when they are persistent and a change from normal for you.

See your doctor if you have these symptoms more than 12 times a month. Ask directly whether ovarian cancer should be ruled out, especially if you have a family history of ovarian or breast cancer.

There is no recommended screening test for women at average risk with no symptoms. Transvaginal ultrasound and the CA-125 blood test led to more testing and surgery in studies of average-risk women, without lowering ovarian cancer deaths. If you have an inherited risk, such as a BRCA mutation or Lynch syndrome, talk with your doctor. See our ovarian cancer guide.

How to ask your doctor about prognosis

You can decide how much you want to know. You might say, "I want the big picture but not numbers," or "Please give me the honest range." You can also bring someone with you and ask them to take notes.

What is the goal of my treatment: cure, control or comfort?
What is my stage, and what is the grade?
Do my tumor's biomarkers change my outlook?
Which statistics apply to me, and how old are they?
Do those figures reflect the treatment I will get?
What would happen if I chose not to have treatment?
Is there a clinical trial for me?

Treatment decisions, side effects, money and legal plans are all fair to raise too. Palliative care teams are used to these conversations. See also our staging guide and glossary.

Frequently asked questions

What does 5-year survival rate mean?

It is the percentage of people with a given cancer who are alive 5 years after diagnosis, usually compared with similar people in the general population. It does not mean people live only 5 years, and many live much longer.

What is the difference between relative and overall survival?

Overall survival counts deaths from any cause. Relative survival compares people with cancer to similar people in the general population, which removes the effect of other causes of death. Relative survival is usually higher, especially for cancers of older adults.

What are the signs of ovarian cancer and what is the survival rate?

Common signs are bloating, pelvic or belly pain, trouble eating or feeling full quickly, and urgent or frequent urination. See a doctor if these happen more than 12 times a month. The 5-year relative survival rate is 52.0% overall: 91.9% for localized, 70.1% for regional and 31.5% for distant cancer (SEER, 2016 to 2022).

What is the survival rate of stage 1 ovarian cancer?

SEER reports 91.9% for localized ovarian cancer, which is cancer that has not spread beyond the ovary, for people diagnosed 2016 to 2022. SEER does not report stage I exactly, but localized is the closest match.

Does 5 years without cancer mean I am cured?

Not necessarily. Five years is a statistical convention, not a cure line. The risk of cancer coming back differs by cancer type. Ask your doctor what is known for your type and how long you need follow-up.

Are survival rates accurate for me?

They are accurate for large groups, not individuals. They reflect people treated years ago and do not include your health, your tumor's biomarkers or how you respond to treatment. Your doctor can tell you how they apply to you.

Do I have to hear my prognosis?

No. Learning your prognosis is a personal choice. You can tell your doctor how much you want to know, ask for the general picture, or ask them to talk with a family member instead.

Sources

This page is general information, not medical advice. Your care team knows your situation and should guide your decisions.